I have worked in this field 20+ years in various capacities . .

I know what I'm talking about.
Take U.S., as an example, please explain why small/mid-sized brand-name pharmas can prosper. But there are no small generic pharmas. I'm talking about generic drug maker, not distributors or those that acquire non-strategic assets from big pharmas.